Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
18F-FDOPA PET/CT for neuroendocrine tumors in multiple endocrine neoplasia type 1.
Journal: Frontiers in endocrinology
Published: April 07, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.
Journal: JCO oncology practice
Published: February 19, 2026
Phase 2 study of cabozantinib (XL184) with nivolumab and ipilimumab for the treatment of poorly differentiated neuroendocrine carcinomas (ETCTN10315).
Journal: The oncologist
Published: January 27, 2026
Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.
Journal: The Prostate
Published: March 25, 2025
Harnessing nature's therapeutic potential: A review of natural products in prostate cancer management.
Journal: Urologic oncology
Published: August 21, 2024
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial.
Journal: Cancer research communications
Published: May 16, 2024
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models.
Journal: The Prostate
Published: February 26, 2024
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 08, 2024
Role of bromodomain and extraterminal (BET) proteins in prostate cancer.
Journal: Expert opinion on investigational drugs
Published: March 01, 2023
Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.
Journal: Journal of the Endocrine Society
Published: March 17, 2022
Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.
Journal: The New England journal of medicine
Published: November 17, 2021
Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus.
Journal: Endocrine-related cancer
Published: September 06, 2021
Last Updated: 09/26/2026